Modulation of Macrophages Activity by Human T-lymphocyte-derived Microparticles Contributes to their Antiangiogenic Effects in Ischemic Retinopathy

人 T 淋巴细胞衍生微粒对巨噬细胞活性的调节有助于其在缺血性视网膜病变中的抗血管生成作用

• 批准号: 342256
• 负责人: Hardy Pierre
• 金额: $ 27.85万
• 依托单位: Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-03-01 至 2020-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342256&lang=en
• 关键词: Antiangiogenesis; Extracellular Microvesicles; Lymphocytic Microparticles; Macrophages; Oxygen-Induced Retinopathy; Retinal Neovascularization; Retinopaghy Of Prematurity; Treatment Of Disease; Vascular Biology

The retina is a light-sensitive layer of cells lining the back of the eye that help us to see. When babies are born too early, the blood vessels on the retina are not fully developed. Retinopathy of prematurity (ROP) is the name for the improper growth of

视网膜是一层感光细胞，排列在眼睛后部，帮助我们看东西。当婴儿过早出生时，视网膜上的血管还没有完全发育。早产儿视网膜病变（ROP）是早产儿视网膜病变的名称。